uploads///mental health _

Analysts Rate Voyager Therapeutics and Its Peers in April

By

Dec. 4 2020, Updated 10:53 a.m. ET

Company overview

Voyager Therapeutics (VYGR) is a clinical-stage gene therapy company with a focus on developing treatments for severe neurological diseases. It focuses on those neurological diseases for which an adeno-associated virus (or AAV) gene therapy can reduce the symptoms experienced by patients.

Voyager has built a product engine that enables it to engineer, optimize, manufacture, and deliver its AAV-based gene therapies. The company is working toward identifying novel AAV capsids, the outer shells that enclose the genetic material of the virus payload.

Article continues below advertisement

Analysts’ recommendations

Of the 13 analysts covering Voyager Therapeutics in April 2018, five have given the stock “strong buy” ratings, five have given it “buy” ratings, and three have given it “hold” ratings. The mean rating for the stock is 1.85, and its target price is $31.46.

Peers’ ratings

Of the seven analysts covering Amicus Therapeutics (FOLD) in April 2018, three analysts have given it “strong buy” ratings, and three have given it “buy” ratings, while one has given it a “hold” rating. The mean rating for the stock is 1.71, and its target price is $19.93.

Of the 20 analysts covering Spark Therapeutics (ONCE) in April 2018, four analysts have given the stock “strong buy” ratings, and ten have given it “buy” ratings. Five analysts have given Spark Therapeutics “hold” ratings, while one has given it a “strong sell” rating. The mean rating for the stock is 2.2, and its target price is $70.05.

Of the six analysts covering uniQure (QURE) in April 2018, two analysts have given the stock “strong buy” ratings, and four have given it “buy” ratings. The mean rating for the stock is 1.67, and its target price is $31.9.

In the next part of the series, we’ll take a look at Voyager Therapeutics’ research pipeline.

Advertisement

More From Market Realist

  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.